Novo Nordisk's brand name for its 20% R/neutral and 80% NPH/isophane crystal insulin which is intermediate-acting. Another comparable insulin, also Novo-made was Mixtard 20. Eli Lilly produced a comparable insulin called Humulin M2; it was discontinued in the EU & UK in July, 2004.
| Attributes | Values |
|---|---|
| rdfs:label |
|
| rdfs:comment |
|
| Strength |
|
| openedlife |
|
| penlife |
|
| dogaction |
|
| handlingnotes |
|
| mfg | |
| shelflife |
|
| cloudyorsoluble | |
| cataction |
|
| generic | |
| dcterms:subject | |
| Origin | |
| Name |
|
| Similar |
|
| dbkwik:petdiabetes...iPageUsesTemplate | |
| Line | |
| Aliases | |
| fgcolor |
|
| BGCOLOR |
|
| - align |
|
| Action | |
| Suspension | |
| abstract |
|
| is Similar of | |
| is Aliases of |